12 research outputs found
Conformational Landscape of N-Glycosylated Peptides Detecting Autoantibodies in Multiple Sclerosis, Revealed by Hamiltonian Replica Exchange
Synthetic N-glycosylated CSF114Â(Glc) and related peptides
were
proved to be able to recognize specific and high-affinity autoantibodies
circulating in blood of relapsing-remitting multiple sclerosis (MS)
patients and correlating with disease activity. The effect of these
peptides has been linked to the β-turn structure around the
minimal epitope AsnÂ(Glc). In this work we performed Hamiltonian replica
exchange molecular dynamics simulations on the central heptapeptide
fragment of a CSF114Â(Glc)-derived peptide in water and in a water/hexafluoroacetone
mixture, confirming a significant incidence of β-turn structures
in both solvents. The structural similarity of the glycosylated and
unglycosylated forms in all environments proves that the conformation
of the heptapeptide is only marginally affected by the presence of
the sugar. Moreover, the presence of a significant amount of bioactive
hairpin-like conformations in the water environment suggests a possible
use not only in the diagnosis but also in the treatment of MS
Designed Glucopeptides Mimetics of Myelin Protein Epitopes As Synthetic Probes for the Detection of Autoantibodies, Biomarkers of Multiple Sclerosis
We previously reported that CSF114Â(Glc) detects diagnostic
autoantibodies in multiple sclerosis sera. We report herein a bioinformatic
analysis of myelin proteins and CSF114Â(Glc), which led to the identification
of five sequences. These glucopeptides were synthesized and tested
in enzymatic assays, showing a common minimal epitope. Starting from
that, we designed an optimized sequence, SP077, showing a higher homology
with both CSF114Â(Glc) and the five sequences selected using the bioinformatic
approach. SP077 was synthesized and tested on 50 multiple sclerosis
patients’ sera, and was able to detect higher antibody titers
as compared to CSF114Â(Glc). Finally, the conformational properties
of SP077 were studied by NMR spectroscopy and structure calculations.
Thus, the immunological activity of SP077 in the recognition of specific
autoantibodies in multiple sclerosis patients’ sera may be
ascribed to both the optimized design of its epitopic region and the
superior surface interacting properties of its C-terminal region
Conformational Analysis of Gly–Ala–NHMe in D<sub>2</sub>O and DMSO Solutions: A Two-Dimensional Infrared Spectroscopy Study
A relevant
number of experiments on short peptides has been performed
in recent years. One of the major problems rises from the simultaneous
presence of slightly different conformers at equilibrium in solution.
In the present paper, the conformational characteristics of the Gly–l-Ala–Methyl amide dipeptide in D<sub>2</sub>O and DMSO
solutions are investigated by nonlinear IR spectroscopy. The pump–probe
scheme with ultrashort mid-infrared pulses, in the Amide I region,
is used to determine the mutual orientation of the two Cî—»O
bonds and the dynamics due to solute–solvent interactions.
The coupling between Amide I modes is evaluated from both linear and
2D spectra. The interconversion between the different conformations
occurs on time scales longer than the vibrational lifetime, and the
spectral diffusion observed in 2D spectra is attributed to the solvent
dynamics. Quantum mechanical calculations and molecular dynamics simulations
are performed to identify the most stable geometries. By comparing
the experimental and the theoretical data, we establish the prevalence
of β-like polar conformers in both water and DMSO solvents
Relationships among DEHP metabolites concentrations in urine normalized by creatinine (expressed as μg/g) in obese children.
<p>C.A.: chronological age; HtSDS: height expressed as standard deviation score. BMISDS: Body mass index expressed as standard deviation score.</p><p>FGIR: Fasting glucose to insulin ratio; WBISI: Whole Body Insulin Sensitivity Index; AUCI: Area under the curve for insulin calculated from the from the Oral Glucose Tolerance Test (OGTT).</p><p>Relationships among DEHP metabolites concentrations in urine normalized by creatinine (expressed as μg/g) in obese children.</p
Geographical distribution of the obese and normal-weight subjects.
<p>The children came from a small area within the Emilia-Romagna region in Italy, mainly between the provinces of Parma and Reggio-Emilia.</p
Concentration of DEHP metabolites in urine normalized by creatinine (espressed as μg/g).
<p>Reported results are from Kruskall-Wallis ANOVA.</p><p>Data are median (25<sup>th</sup>-75<sup>th</sup> percentile);</p><p>vs: versus.</p><p>Concentration of DEHP metabolites in urine normalized by creatinine (espressed as μg/g).</p
Metabolism of DEHP.
<p>(A) Hydrolytic/oxidative pathway leading to MEHP and secondary metabolite formation. (B) Formation of glucuronic conjugates of DEHP metabolites.</p
Relationships among DEHP metabolites concentration in urine normalized by creatinine (espressed as μg/g) in normal-weight children.
<p>5-oxo-MEHP correlated positively with both HtSDS (rho:0.579; p<0.002) and BMISDS (rho:0.441; p<0.015; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0117831#pone.0117831.t005" target="_blank">Table 5</a>).</p><p>Relationships among DEHP metabolites concentration in urine normalized by creatinine (espressed as μg/g) in normal-weight children.</p
Concentration and distribution of single DEHP metabolites in urine.
<p>(A) control subject and (B) obese children and adolescents.</p
Semantic Connectivity Map linking DEHP metabolites.
<p>Analysis with auxological parameters and measurements of insulin sensitivity in normal-weight and obese children and adolescents. Values ranging from 0 (no association) to 1 (the strongest association) express the strength of association.</p